Cargando…
Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy
Immune checkpoint inhibitors have advanced the treatment paradigm of various cancers, achieving remarkable survival benefits. However, a myriad of immune-related adverse events (irAE) has been recognized in almost every organ system, presumably because of persistent immune system activation. Rheumat...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900912/ https://www.ncbi.nlm.nih.gov/pubmed/31816084 http://dx.doi.org/10.1093/rheumatology/kez297 |